ACET Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 19.10%

Insider Buying (Last 12 Months): $7,500,000.00

Insider Selling (Last 12 Months): $8,437.00

Adicet Bio Insider Trading History Chart

Adicet Bio Share Price & Price History

^$0.96

▼ -0.0097 (-1.00%)

As of 11/21/2024 03:00 PM ET

Days: 30 | 90 | 365

Urgent: This election is rigged

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

Adicet Bio Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/5/2024	Michael Kauffman	Director	Sell	5,900	$1.43	$8,437.00	5,900
1/25/2024	Orbimed Advisors Llc	Director	Buy	3,125,000	$2.40	$7,500,000.00	7,526,359
10/2/2023	Chen Schor	CEO	Buy	5,500	$1.33	$7,315.00	43,469
9/28/2023	Chen Schor	CEO	Buy	5,500	$1.42	$7,810.00	182,469
6/30/2023	Steve Dubin	Director	Buy	5,000	$2.40	$12,000.00	10,900
6/27/2023	Carl L Gordon	Director	Buy	875,000	$2.09	$1,828,750.00	5,685,259
2/15/2023	Don Healey	CTO	Sell	4,533	$7.57	$34,314.81	66,568
2/10/2023	Don Healey	CTO	Sell	10,467	$7.98	$83,526.66	71,101
11/10/2022	Blake Aftab	Insider	Sell	6,967	$21.00	$146,307.00	28,209
11/10/2022	Chen Schor	CEO	Sell	9,955	$21.03	$209,353.65	91,469
11/2/2022	Chen Schor	CEO	Sell	500	$18.00	$9,000.00	138,237
10/19/2022	Blake Aftab	Insider	Sell	8,067	$16.27	$131,250.09	35,176
10/12/2022	Blake Aftab	Insider	Sell	1,646	$15.40	$25,348.40	51,176
9/14/2022	Chen Schor	CEO	Sell	952	$18.00	$17,136.00	138,737
9/12/2022	Chen Schor	CEO	Sell	66,947	$16.77	$1,122,701.19	122,712
9/9/2022	Chen Schor	CEO	Sell	8,094	$16.51	$133,631.94	66,747
8/3/2022	Blake Aftab	Insider	Sell	6,968	$18.00	$125,424.00	38,967
8/1/2022	Blake Aftab	Insider	Sell	6,968	$16.64	$115,947.52	45,935
7/5/2022	Blake Aftab	Insider	Sell	1,363	$14.50	$19,763.50	52,903
4/4/2022	Francesco Galimi	SVP	Sell	7,979	$21.00	$167,559.00	59,917
4/1/2022	Francesco Galimi	SVP	Sell	7,621	$21.00	$160,041.00	59,917
2/16/2022	Aya Jakobovits	Director	Sell	4,000	$14.83	$59,320.00
2/9/2022	Aya Jakobovits	Director	Sell	8,000	$14.03	$112,240.00
1/5/2022	Aya Jakobovits	Director	Sell	4,000	$16.92	$67,680.00
1/3/2022	Aya Jakobovits	Director	Sell	12,000	$18.02	$216,240.00
12/8/2021	Andrew Sinclair	Director	Buy	500,000	$14.00	$7,000,000.00

📉 Warning: Market Crash Predicted - Secure Your Savings

From Behind the Markets | Ad

The last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.

Take these 4 steps to protect your retirement here >>>

SEC Filings (Institutional Ownership Changes) for Adicet Bio (NASDAQ:ACET)

83.89% of Adicet Bio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Adicet Bio Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/16/2024	Geode Capital Management LLC	768,566	$1.11M	0.0%	+14.5%	0.933%
11/15/2024	XTX Topco Ltd	292,180	$0.42M	0.0%	+12.5%	0.355%
11/15/2024	Jane Street Group LLC	74,767	$0.11M	0.0%	-63.9%	0.091%
11/15/2024	State Street Corp	229,721	$0.33M	0.0%	-6.2%	0.279%
11/15/2024	RBF Capital LLC	601,135	$0.87M	0.0%	+62.5%	0.730%
11/15/2024	Point72 Asia Singapore Pte. Ltd.	41,115	$59K	0.0%	-19.2%	0.050%
11/13/2024	FMR LLC	276,169	$0.40M	0.0%	+31.3%	0.335%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	180,793	$0.26M	0.0%	-15.1%	0.219%
11/6/2024	Cornercap Investment Counsel Inc.	18,074	$26K	0.0%	-53.3%	0.022%
11/5/2024	GSA Capital Partners LLP	39,208	$56K	0.0%	+161.3%	0.048%
10/21/2024	Castleview Partners LLC	52,368	$75K	0.0%	N/A	0.064%
9/16/2024	Point72 DIFC Ltd	33,441	$40K	0.0%	+77.5%	0.041%
9/16/2024	Cubist Systematic Strategies LLC	409,049	$0.50M	0.0%	+790.1%	0.496%
9/16/2024	Point72 Asia Singapore Pte. Ltd.	50,888	$62K	0.0%	N/A	0.062%
8/21/2024	Stonepine Capital Management LLC	609,446	$0.74M	0.7%	+330.6%	0.740%
8/15/2024	Millennium Management LLC	3,621,670	$4.38M	0.0%	-11.8%	4.408%
8/15/2024	AQR Capital Management LLC	136,765	$0.17M	0.0%	+478.3%	0.166%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	50,888	$62K	0.0%	N/A	0.062%
8/14/2024	Squarepoint Ops LLC	362,230	$0.44M	0.0%	+2,728.8%	0.441%
8/14/2024	Cubist Systematic Strategies LLC	409,049	$0.50M	0.0%	+790.1%	0.498%
8/14/2024	Point72 DIFC Ltd	33,441	$40K	0.0%	+77.5%	0.041%
8/14/2024	Marshall Wace LLP	35,323	$43K	0.0%	N/A	0.043%
8/12/2024	XTX Topco Ltd	259,788	$0.31M	0.0%	+14.9%	0.316%
8/9/2024	Renaissance Technologies LLC	1,512,600	$1.83M	0.0%	+44.2%	1.841%
8/9/2024	Dimensional Fund Advisors LP	147,814	$0.18M	0.0%	-21.9%	0.180%
8/8/2024	American Century Companies Inc.	76,087	$92K	0.0%	+22.9%	0.093%
8/7/2024	Cowen AND Company LLC	801,298	$0.97M	0.0%	-6.8%	0.975%
8/6/2024	Acadian Asset Management LLC	1,085,093	$1.31M	0.0%	+205.4%	1.321%
8/1/2024	Rhumbline Advisers	20,819	$25K	0.0%	-65.6%	0.025%
5/17/2024	RA Capital Management L.P.	7,541,000	$17.72M	0.2%	N/A	9.177%
5/16/2024	Bayesian Capital Management LP	38,421	$90K	0.0%	N/A	0.047%
5/16/2024	Blackstone Inc.	1,236,453	$2.91M	0.0%	N/A	1.505%
5/15/2024	Price T Rowe Associates Inc. MD	15,344	$37K	0.0%	N/A	0.019%
5/14/2024	American International Group Inc.	26,319	$62K	0.0%	+74.2%	0.032%
5/10/2024	Acadian Asset Management LLC	355,343	$0.83M	0.0%	-36.5%	0.432%
5/10/2024	Vanguard Group Inc.	3,126,578	$7.35M	0.0%	+85.5%	3.805%
5/10/2024	Johnson & Johnson	364,472	$0.86M	0.0%	-47.1%	0.444%
5/3/2024	Carlyle Group Inc.	2,948,718	$6.90M	0.4%	+39.4%	3.589%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	11,833	$28K	0.0%	N/A	0.014%
2/14/2024	RTW Investments LP	4,134,631	$7.81M	0.1%	-2.5%	5.893%
2/8/2024	Panagora Asset Management Inc.	51,746	$98K	0.0%	N/A	0.074%
1/5/2024	Exchange Traded Concepts LLC	81,986	$0.16M	0.0%	+34.0%	0.190%
11/29/2023	Decheng Capital Management III Cayman LLC	200,201	$0.27M	0.1%	-60.4%	0.464%
11/13/2023	Acadian Asset Management LLC	523,009	$0.72M	0.0%	+2,182.5%	1.212%
11/9/2023	Cowen AND Company LLC	2,715,278	$3.72M	0.3%	-4.2%	6.304%
10/30/2023	Summit Trail Advisors LLC	18,000	$25K	0.0%	+80.0%	0.042%
10/27/2023	Marquette Asset Management LLC	28,144	$39K	0.0%	N/A	0.065%
10/27/2023	Acuitas Investments LLC	136,779	$0.19M	0.1%	N/A	0.318%
10/24/2023	Bank of New York Mellon Corp	131,393	$0.18M	0.0%	+30.3%	0.305%
10/18/2023	Exchange Traded Concepts LLC	61,196	$84K	0.0%	+107.5%	0.142%
8/8/2023	Candriam S.C.A.	715,890	$1.74M	0.0%	-41.8%	1.666%
8/7/2023	Acadian Asset Management LLC	22,914	$54K	0.0%	N/A	0.053%
8/7/2023	Cowen AND Company LLC	2,834,864	$6.89M	0.6%	-9.8%	6.599%
7/28/2023	Decheng Capital Management III Cayman LLC	505,668	$1.23M	0.4%	-12.8%	1.177%
7/27/2023	Virtu Financial LLC	16,097	$39K	0.0%	N/A	0.037%
7/20/2023	Exchange Traded Concepts LLC	29,490	$72K	0.0%	N/A	0.069%
6/1/2023	Golden State Equity Partners	23,830	$0.14M	0.1%	N/A	0.055%
5/11/2023	Skandinaviska Enskilda Banken AB publ	42,232	$0.24M	0.0%	-4.6%	0.098%
5/10/2023	Simplify Asset Management Inc.	26,900	$0.16M	0.0%	N/A	0.063%
5/9/2023	Russell Investments Group Ltd.	174,710	$1.01M	0.0%	+59.2%	0.407%
5/5/2023	Carlyle Group Inc.	2,115,385	$12.16M	0.4%	N/A	4.924%
5/3/2023	Jump Financial LLC	41,300	$0.24M	0.0%	N/A	0.096%
4/28/2023	SG Americas Securities LLC	12,834	$74K	0.0%	+17.4%	0.030%
3/23/2023	MetLife Investment Management LLC	15,993	$0.14M	0.0%	+25.8%	0.037%
2/15/2023	Tang Capital Management LLC	600,000	$5.36M	0.8%	N/A	1.400%
2/14/2023	Alpine Global Management LLC	12,189	$0.11M	0.0%	N/A	0.028%
2/14/2023	EcoR1 Capital LLC	3,560,700	$31.83M	1.0%	N/A	8.310%
2/13/2023	BML Capital Management LLC	30,000	$0.27M	0.3%	N/A	0.070%
2/13/2023	Foresite Capital Management V LLC	558,636	$4.99M	3.9%	-17.8%	1.304%
2/10/2023	AXQ Capital LP	12,964	$0.12M	0.1%	N/A	0.030%
2/9/2023	Principal Financial Group Inc.	16,865	$0.15M	0.0%	N/A	0.039%
2/9/2023	Cowen AND Company LLC	3,143,608	$28.10M	2.9%	+28.7%	7.336%
2/9/2023	Citigroup Inc.	80,040	$0.72M	0.0%	-33.4%	0.187%
2/8/2023	Skandinaviska Enskilda Banken AB publ	44,277	$0.40M	0.0%	-5.5%	0.103%
2/8/2023	Swiss National Bank	43,500	$0.39M	0.0%	+2.8%	0.102%
2/8/2023	Russell Investments Group Ltd.	109,740	$0.98M	0.0%	+15.4%	0.256%
2/2/2023	SG Americas Securities LLC	10,936	$98K	0.0%	-22.0%	0.026%
2/1/2023	Zurcher Kantonalbank Zurich Cantonalbank	7,161	$64K	0.0%	+328.3%	0.017%
1/24/2023	Ziegler Capital Management LLC	38,750	$0.35M	0.0%	-4.0%	0.090%
1/23/2023	Allspring Global Investments Holdings LLC	23,462	$0.21M	0.0%	-49.6%	0.055%
1/12/2023	Assenagon Asset Management S.A.	32,960	$0.30M	0.0%	-92.1%	0.077%
11/17/2022	Telemetry Investments L.L.C.	22,541	$0.32M	0.4%	-14.9%	0.053%
11/15/2022	Laurion Capital Management LP	90,849	$1.29M	0.0%	-79.4%	0.212%
11/15/2022	Ensign Peak Advisors Inc	109,389	$1.56M	0.0%	+11.1%	0.255%
11/14/2022	Annandale Capital LLC	4,600	$65K	0.0%	N/A	0.011%
11/14/2022	RTW Investments LP	4,241,472	$60.31M	1.4%	+7.3%	9.898%
11/14/2022	Cormorant Asset Management LP	1,400,000	$19.91M	1.4%	-22.2%	3.267%
11/14/2022	Point72 Asset Management L.P.	113,834	$1.62M	0.0%	-8.9%	0.266%
11/14/2022	RA Capital Management L.P.	2,059,372	$29.28M	0.6%	N/A	4.806%
11/14/2022	Skandinaviska Enskilda Banken AB publ	46,842	$0.67M	0.0%	N/A	0.109%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	124,379	$1.77M	0.0%	+252.4%	0.311%
11/8/2022	Allianz Asset Management GmbH	33,500	$0.48M	0.0%	-75.9%	0.084%
11/8/2022	Sofinnova Investments Inc.	491,965	$7M	0.4%	-5.1%	1.229%
11/8/2022	International Biotechnology Trust PLC	154,708	$2.20M	0.7%	N/A	0.386%
11/4/2022	Granite Point Capital Management L.P.	45,000	$0.64M	0.3%	-77.3%	0.112%
11/4/2022	Russell Investments Group Ltd.	95,089	$1.35M	0.0%	+86.4%	0.238%
11/3/2022	Barclays PLC	82,407	$1.17M	0.0%	+5,703.3%	0.206%
11/2/2022	Victory Capital Management Inc.	35,478	$0.50M	0.0%	+53.5%	0.089%
11/1/2022	Tekla Capital Management LLC	40,329	$0.57M	0.0%	-36.3%	0.101%
10/31/2022	SG Americas Securities LLC	14,017	$0.20M	0.0%	+27.6%	0.035%

Data available starting January 2016

Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. The company offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable activity in patients. Its lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. The company is also developing ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma for treating other CD70+ solid tumor and hematological malignancies indications. The company was founded in 2014 and is based in Boston, Massachusetts.

Today's Range

Now: $0.96

$0.92

$0.98

50 Day Range

MA: $1.36

$0.95

$1.53

52 Week Range

Now: $0.96

$0.92

$3.77

Volume

487,343 shs

Average Volume

1,102,754 shs

Market Capitalization

$78.89 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.81

Who are the company insiders with the largest holdings of Adicet Bio?: Adicet Bio's top insider investors include:
Orbimed Advisors Llc (Director)
Carl L Gordon (Director)
Chen Schor (CEO)
Don Healey (CTO)
Steve Dubin (Director)
Michael Kauffman (Director)
Learn More about top insider investors at Adicet Bio.
Who are the major institutional investors of Adicet Bio?: Adicet Bio's top institutional shareholders include:
Geode Capital Management LLC — 0.93%
RBF Capital LLC — 0.73%
XTX Topco Ltd — 0.35%
FMR LLC — 0.34%
State Street Corp — 0.28%
Connor Clark & Lunn Investment Management Ltd. — 0.22%
Learn More about top institutional investors of Adicet Bio stock.
Which institutional investors are selling Adicet Bio stock?: In the previous quarter, ACET stock was sold by these institutional investors:
Jane Street Group LLC
Connor Clark & Lunn Investment Management Ltd.
Cornercap Investment Counsel Inc.
State Street Corp
Point72 Asia Singapore Pte. Ltd.
Which institutional investors are buying Adicet Bio stock?: During the previous quarter, ACET stock was bought by institutional investors including:
RBF Capital LLC
Geode Capital Management LLC
FMR LLC
Castleview Partners LLC
XTX Topco Ltd
GSA Capital Partners LLP
During the previous year, these company insiders have bought Adicet Bio stock:
Orbimed Advisors Llc (Director)
Carl L Gordon (Director)
Chen Schor (CEO)
Don Healey (CTO)
Learn More investors buying Adicet Bio stock.